FDA Postpones Enforcement of Combination Product Rules

The GMP Letter
A A
The FDA issued two guidances on postmarketing safety reporting for combination products, pushing back reporting requirements for certain combination products and clarifying reporting rules for their constituent parts.

To View This Article:

Login

Subscribe To The GMP Letter